Vectorite Biomedical Inc. (TPEX:4170)

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Cellular Products	28.67M
Cellular Products Growth	0.59%
Pharmaceutical Services	20.95M
Pharmaceutical Services Growth	2.99%
Stored Income	4.46M
Stored Income Growth	-1.11%
Cell Collection and Processing	2.28M
Cell Collection and Processing Growth	109.19%
Other	1.42M
Other Growth	0.28%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Taiwan	57.66M
Taiwan Growth	3.24%
China	110.00K